The Relative Strength (RS) Rating for Doximity jumped into a higher percentile Thursday, as it got a lift from 64 to 72. It still has room to improve before it hits the 80+ target.
When looking for the best stocks to buy and watch, one factor to watch closely is relative price strength.
This exclusive rating from Investor's Business Daily measures price movement with a 1 (worst) to 99 (best) score. The rating shows how a stock's price performance over the last 52 weeks holds up against all the other stocks in our database.
Decades of market research reveals that the stocks that go on to make the biggest gains typically have an RS Rating north of 80 as they launch their biggest runs. See if Doximity can continue to show renewed price strength and hit that benchmark.
Looking For The Best Stocks To Buy And Watch? Start Here
Doximity is trying to complete a cup without handle with a 40.22 buy point. It is currently working on the right side of the base, and still may form a handle. See if the stock can break out in heavy trading.
Earnings Preview
Doximity reported -24% earnings growth in its most recent report. Sales rose 18%. Look for the next report on or around May 17.
The company earns the No. 5 rank among its peers in the Computer Software-Medical industry group. Evolent Health and Hims & Hers Health are also among the group's highest-rated stocks.
Stocks To Buy And Watch: Top IPOs, Big And Small Caps, Growth Stocks
